- Results from the anonymous online survey, published in the journal Crohn’s & Colitis, examined IBD severity, medication adherence, quality of life, as well as medicinal cannabis use and its perceived impact on these measures.
- Crohn’s disease, ulcerative colitis or IBD unclassified; and different cannabis use populations non-user, previous user and current self-prescribed medicinal cannabis users.
- More than 90 percent of patients reported that medicinal cannabis use improved their symptom management with greatest benefits reported for abdominal pain, stress, sleep, cramping and anxiety symptoms.
- Both cannabis-using and non-using patients expressed high levels of support for the use of medicinal cannabis in IBD and interest in participating in future clinical trials of medicinal cannabis products.
Read full article: en.brinkwire.com